Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM166A, pseudogene 2 (ENSG00000256986) is a processed pseudogene located in the human genome. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional due to accumulated mutations and the lack of necessary regulatory elements or an uninterrupted reading frame. There is no evidence that FAM166A, pseudogene 2 is transcribed into RNA or translated into a protein, nor is it involved in any known biological processes or diseases relevant to human health or therapeutics. It does not represent a receptor or any molecule classically targeted by drugs, and it is generally excluded from gene-focused experimental or clinical efforts.
None (No mechanism of action relevant for drug interaction)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 166, member A pseudogene 2 (FAM166A, pseudogene 2).